-nersen
Antisense drugs aimed at nervous-system disease, like nusinersen.
- Drugs ending in -nersen: 19
- Approved somewhere: 1
- With a US drug page: 3
- Stem
- -nersen
- Class
- Antisense drugs aimed at nervous-system disease, like nusinersen
- Sub-stem of
- -rsen: Antisense oligonucleotides, which bind a gene's RNA to block or alter it
- Most common targets
- p53 mRNA (2), SMN2 pre-mRNA (1), Huntingtin mRNA (1)
Approved and clinical-stage drugs in ChEMBL whose names ending in -nersen, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Nusinersen | Approved | SMN2 pre-mRNA | SMN2 pre-mRNA positive modulator |
| Zilganersen | Phase 3 | — | — |
| Zilganersen sodium | Phase 1 | — | — |
| Tominersen | Phase 3 | Huntingtin mRNA | Huntingtin mRNA antisense inhibitor |
| Cenersen | Phase 2 | p53 mRNA | p53 mRNA antisense inhibitor |
| Cenersen sodium | Phase 2 | p53 mRNA | p53 mRNA antisense inhibitor |
| Lexanersen | Phase 1 | — | — |
| Obudanersen | Phase 1 | — | — |
| Obudanersen sodium | Phase 1 | — | — |
| Rovanersen | Phase 1 | — | — |
| Rovanersen sodium | Phase 1 | — | — |
| Rugonersen | Phase 1 | — | — |
| Rugonersen sodium | Phase 1 | — | — |
| Salanersen | Phase 1 | — | — |
| Tadnersen sodium | Phase 1 | — | — |
| Ulefnersen | Phase 1 | — | — |
| Ulefnersen sodium | Phase 1 | — | — |
| Zorevunersen | Phase 1 | — | — |
| Zorevunersen sodium | Phase 1 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO